-
How the May 2025 ODAC Meeting Could Still Impact Future Lung Cancer Clinical Trials
The US Food and Drug Administration (FDA) Oncologic Drug Advisory Committee (ODAC) convened on May 20th and 21st to weigh in on four different regimens across a variety of cancer -
Transforming Cinical Trials Initiative 2025 Second Quarter Updates
The Transforming Clinical Trials Initiative (TCTI) hit the ground running in 2025 to help develop novel solutions to complex challenges in the development of new tools and
